Skip to main content
SpringerLink
Log in

Patient-reported outcome labelling still rare in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. funded by Millennium Pharmaceuticals

Reference

  • Gnanasakthy A, et al. Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014). Journal of Clinical Oncology : 11 Apr 2016

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patient-reported outcome labelling still rare in the US. PharmacoEcon Outcomes News 752, 31 (2016). https://doi.org/10.1007/s40274-016-3025-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3025-1

Search

Navigation